Can training memory and attention on a home computer-task reduce spatial awareness problems after stroke?
Today, the Association of Medical Research Charities (AMRC) launched a new spotlight report highlighting the positive difference medical research charities are making for mental health patients across the UK.
On Monday 16th June the Stroke Association were invited to share how research we funded has changed lives at the All-Party Parliamentary Group on Medical Research Summer Reception, entitled, "A Healthy Future for UK Medical Research".
This study is investigating whether colchicine, a medication used to treat gout, could help to stop people who have previously had a stroke or TIA from having further strokes.
Published online first in the journal Neurology, a new study suggests that people with AF who have an ICH due to their medication have similar outcomes whether they're on a NOAC or a vitamin K antagonist drug.
The Medical Research Council (MRC) has launched a new £5m call for capital investment to support between two and five human tissue banks with linked data resources. Awards will be made to teams of academics working in close partnership with medical research charities.
The Stroke Association is pleased to support the AllTrials campaign and has signed the petition for all clinical trials to be registered and published.
Most stroke and transient ischaemic attack (TIA) survivors are asked to take medicines, which some can find difficult. However, taking the medicines prescribed after a stroke, or TIA, and following lifestyle advice can reduce the chance of another stroke by 80%.
Medical research is essential to develop new treatments and therapies for stroke so that patients in the UK can get the best possible care. Clinical trials are conducted to test whether a new medical intervention is safe and effective and these trials often rely on the participation of volunteer stroke survivors.
This research project aims to better understand how particular features of the CT scan can be used to make better treatment decisions for patients with ischaemic stroke, and whether we can accurately estimate the time since the stroke began.